PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
32 hedge funds and large institutions have $38.5M invested in PLx Pharma Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 7 reducing their positions, and 7 closing their positions.
129% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 7
51% more capital invested
Capital invested by funds: $25.5M → $38.5M (+$13M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 33 → 32 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.11M |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$357K |
| 3 |
1CM
1492 Capital Management
Milwaukee,
Wisconsin
|
+$318K |
| 4 |
EA
Emerald Acquisition
Seattle,
Washington
|
+$287K |
| 5 |
TCM
Timpani Capital Management
Milwaukee,
Wisconsin
|
+$216K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$444K |
| 2 |
FPC
Falcon Point Capital
San Francisco,
California
|
-$385K |
| 3 |
KCM
Kingdon Capital Management
New York
|
-$291K |
| 4 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$246K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$244K |
PLXP Hedge Fund Activity: Q3 2016 in Review
32 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q3 2016, worth a combined $38.5M — up 51% from $25.5M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of PLXP and 6 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 16 added.
The largest buyer was Great Point Partners, adding an estimated $1.11M. The largest seller was Broadfin Capital, exiting entirely with an estimated $444K sold.
- 32 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q3 2016, down from 33 in Q2 2016.
- Funds reported $38.5M of PLx Pharma Inc. Common Stock stock for Q3 2016, up 51% quarter-over-quarter.
- 6 funds opened new PLx Pharma Inc. Common Stock positions in Q3 2016 and 7 closed out, a net change of -1 holder.
- The largest PLx Pharma Inc. Common Stock buyer in Q3 2016 was Great Point Partners, an estimated $1.11M added.
- The largest PLx Pharma Inc. Common Stock seller in Q3 2016 was Broadfin Capital, an estimated $444K sold.
Based on aggregated 13F filings for Q3 2016.